Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Pellini Michael J
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director OWEN KATEY EINTERZ
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director GRIFFIN MICHELLE RENEE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Stacy L
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer LO FRANCIS
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BENZENO SHARON
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer RUBINSTEIN JULIE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer ROBINS HARLAN S
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PETERSON TYCHO
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer ROBINS CHAD M
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BOBULSKY SUSAN
Adaptive Biotechnologies | 3: Initial statement of beneficial ownership of securities-Officer BOBULSKY SUSAN
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(20.7%),O. Andreas Halvorsen(20.7%), etc.
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.82%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(8.85%)
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.9%)
No Data